Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis
Susan G. R. McDuff, Theodore S. Hong(Massachusetts General Hospital), Hui Zheng(Harvard University), Aparna R. Parikh(Massachusetts General Hospital), Kenneth K. Tanabe(Harvard University), Lipika Goyal(Stanford Medicine), Cristina R. Ferrone(Cedars-Sinai Medical Center), David P. Ryan(East Carolina University), Jennifer Y. Wo(Massachusetts General Hospital), Ann C. Raldow(University of California, Los Angeles), Lawrence S. Blaszkowsky(Brigham and Women's Hospital), Jeffrey W. Clark(Massachusetts General Hospital), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), John A. Wolfgang(Massachusetts General Hospital), Jill N. Allen(Harvard University), Christine E. Eyler(Duke University), Lorraine C. Drapek(Harvard University), Kyla Remillard(Massachusetts General Hospital)
Cited by 28
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k